Earnings Per Share, Basic of Vitro Biopharma, Inc. from 31 Jul 2010 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Vitro Biopharma, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Jul 2010 to 31 Oct 2025.
  • Vitro Biopharma, Inc. Earnings Per Share, Basic for the quarter ending 31 Oct 2025 was -1.09, a 142% decline year-over-year.
  • Vitro Biopharma, Inc. Earnings Per Share, Basic for the twelve months ending 31 Oct 2025 was -2.44, a 10% decline year-over-year.
  • Vitro Biopharma, Inc. annual Earnings Per Share, Basic for 2025 was -2.44, a 10% decline from 2024.
  • Vitro Biopharma, Inc. annual Earnings Per Share, Basic for 2024 was -2.21, a 83% decline from 2023.
  • Vitro Biopharma, Inc. annual Earnings Per Share, Basic for 2023 was -1.21, a 35% increase from 2022.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Vitro Biopharma, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 -2.44 -1.09 -0.64 -142% 01 Aug 2025 31 Oct 2025 10-K 13 Feb 2026 2025 FY
Q2 2025 -1.8 -0.38 -0.35 -1167% 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2025 Q3
Q1 2025 -1.45 -0.33 +0.37 +53% 01 Feb 2025 30 Apr 2025 10-Q 20 Jun 2025 2025 Q2
Q4 2024 -1.82 -0.64 +0.39 +38% 01 Nov 2024 31 Jan 2025 10-Q 20 Mar 2025 2025 Q1
Q3 2024 -2.21 -0.45 -0.03 -7.1% 01 Aug 2024 31 Oct 2024 10-K 13 Feb 2026 2025 FY
Q2 2024 -2.18 -0.03 +0.17 +85% 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2025 Q3
Q1 2024 -2.35 -0.7 -0.38 -119% 01 Feb 2024 30 Apr 2024 10-Q 20 Jun 2025 2025 Q2
Q4 2023 -1.97 -1.03 -0.76 -281% 01 Nov 2023 31 Jan 2024 10-Q 20 Mar 2025 2025 Q1
Q3 2023 -1.21 -0.42 +0.81 +66% 01 Aug 2023 31 Oct 2023 10-K 28 Jan 2025 2024 FY
Q2 2023 -2.02 -0.2 +0.42 +68% 01 May 2023 31 Jul 2023 10-Q 16 Sep 2024 2024 Q3
Q1 2023 -2.44 -0.32 -0.3 -1500% 01 Feb 2023 30 Apr 2023 10-Q 31 May 2024 2024 Q2
Q4 2022 -2.14 -0.27 -0.27 01 Nov 2022 31 Jan 2023 10-Q 14 Mar 2024 2024 Q1
Q3 2022 -1.87 -1.23 01 Aug 2022 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 -0.62 01 May 2022 31 Jul 2022 10-Q 28 Aug 2023 2023 Q3
Q1 2022 -0.02 01 Feb 2022 30 Apr 2022 10-Q 13 Jun 2023 2023 Q2
Q4 2021 0 01 Nov 2021 31 Jan 2022 10-Q 14 Mar 2023 2023 Q1
Q2 2012 0 0 01 May 2012 31 Jul 2012 10-Q/A 17 Oct 2012 2012 Q3
Q4 2011 0 0 01 Nov 2011 31 Jan 2012 10-Q 21 Mar 2012 2012 Q1
Q2 2011 0 0 01 May 2011 31 Jul 2011 10-Q/A 17 Oct 2012 2012 Q3
Q4 2010 0 01 Nov 2010 31 Jan 2011 10-Q 21 Mar 2012 2012 Q1
Q2 2010 0 01 May 2010 31 Jul 2010 10-Q/A 12 Oct 2011 2011 Q3

Vitro Biopharma, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 -2.44 -0.23 -10% 01 Nov 2024 31 Oct 2025 10-K 13 Feb 2026 2025 FY
2024 -2.21 -1 -83% 01 Nov 2023 31 Oct 2024 10-K 13 Feb 2026 2025 FY
2023 -1.21 +0.66 +35% 01 Nov 2022 31 Oct 2023 10-K 28 Jan 2025 2024 FY
2022 -1.87 01 Nov 2021 31 Oct 2022 10-K 29 Jan 2024 2023 FY
2011 0 +0.01 01 Nov 2010 31 Oct 2011 10-K/A 16 Feb 2012 2011 FY
2010 -0.01 01 Nov 2009 31 Oct 2010 10-K/A 16 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.